Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Baxter
Moodys
Colorcon
Boehringer Ingelheim

Last Updated: April 9, 2020

DrugPatentWatch Database Preview

OXYCODONE 2.5/APAP 500 Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

When do Oxycodone 2.5/apap 500 patents expire, and what generic alternatives are available?

Oxycodone 2.5/apap 500 is a drug marketed by Bristol Myers Squibb and is included in one NDA.

The generic ingredient in OXYCODONE 2.5/APAP 500 is acetaminophen; oxycodone hydrochloride. There are sixty-six drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the acetaminophen; oxycodone hydrochloride profile page.

Summary for OXYCODONE 2.5/APAP 500
Drug patent expirations by year for OXYCODONE 2.5/APAP 500
Recent Clinical Trials for OXYCODONE 2.5/APAP 500

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Orthopedic Research and Education FoundationPhase 4
The George Washington University Biostatistics CenterPhase 3
The First Affiliated Hospital with Nanjing Medical UniversityN/A

See all OXYCODONE 2.5/APAP 500 clinical trials

US Patents and Regulatory Information for OXYCODONE 2.5/APAP 500

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb OXYCODONE 2.5/APAP 500 acetaminophen; oxycodone hydrochloride TABLET;ORAL 085910-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Baxter
Moodys
Colorcon
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.